Sandbox/ttt1

Thymoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thymoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Sandbox/ttt1 On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sandbox/ttt1 All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sandbox/ttt1
CDC on Sandbox/ttt1
Sandbox/ttt1 in the news
Blogs on Sandbox/ttt1
Directions to Hospitals Treating Thymoma
Risk calculators and risk factors for Sandbox/ttt1

Pathology evaluation

R0 Resection

R2 Resection

R1 Resection

Thymoma, no capsular invasion or thymic carcinoma,stage I

Thymoma or thymic carcinoma, capsular invasion presents stages II-IV

Thymoma

Thymic carcinoma

Thymoma

Thymic carcinoma

Surveillance for recurrence with CT every 6 month for 2 y, then annually every 5 y for thymic carcinoma and 10 y for thymoma

Consider postoperative RT

Postoperative RT

Postoperative RT+chemotherapy

RT +/- chemotherapy

RT +/- chemotherapy

Surveillance for recurrence with CT every 6 month for 2 y, then annually every 5 y for thymic carcinoma and 10 y for thymoma

Relapse(check recurrence algorithm)

Relapse(check recurrence algorithm)